LIGAND PHARMACEUTICALS INCORPORATED Restricted Cash, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Restricted Cash, Current of $583.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Restricted Cash and Investments, Current
us-gaap:RestrictedCashCurrent · last filed 2023-11-09
- 2023-09-30: Restricted Cash, Current $583.00K.
- 2022-12-31: Restricted Cash, Current $0.00.
- 2022-09-30: Restricted Cash, Current $0.00.
- 2022-06-30: Restricted Cash, Current $0.00.
| Period end | Restricted Cash, Current | Restricted Cash, Current as first filed |
|---|---|---|
| 2023-09-30 | $583.00K 10-Q · filed 2023-11-09 | |
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 | |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $144.00K 10-Q · filed 2022-08-09 | |
| 2021-03-31 | $344.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $343.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | $190.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $730.00K 10-Q · filed 2021-08-03 | |
| 2020-03-31 | $730.00K 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $730.00K 10-K · filed 2022-02-28 | |
| 2019-09-30 | $1.01M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $1.35M 10-Q · filed 2020-08-07 | |
| 2019-03-31 | $2.26M 10-Q · filed 2020-05-08 | |
| 2018-12-31 | $2.62M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-08 | $43.65M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $0.00 10-K · filed 2020-02-27 |